Chris Rubino

Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue

Michael W. Dunne, Sailaja Puttagunta, Craig R. Sprenger et al. · Antimicrobial Agents and Chemotherapy · 2015 · 228 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults

Chris Rubino, Sujata M. Bhavnani, Paul G. Ambrose et al. · Pulmonary Pharmacology & Therapeutics · 2009 · 97 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Use of a clinically derived exposure–response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints

Paul G. Ambrose, Alison Meagher, Julie Passarell et al. · Diagnostic Microbiology and Infectious Disease · 2008 · 19 citations

Life Sciences, Infectious Diseases, Antimicrobial Pharmacology +13

88 Levofloxacin pharmacokinetics (PK) after administration of MP-376 (Levofloxacin inhalation solution; Aeroquin) in children with cystic fibrosis (CF)

Gregory L. Kearns, Chris Rubino, David C. Griffith et al. · Journal of Cystic Fibrosis · 2011 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

First-in-human investigation of the oral first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640.

Andrew Brenner, Daniel D. Von Hoff, Jeffrey R. Infante et al. · Journal of Clinical Oncology · 2015 · 17 citations

Life Sciences, Oncology, Pharmacology +17